Merve Mutlu

Merve Mutlu

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4459291
-
person_outline Merve Mutlu's MOST POPULAR ARTICLES
1-) miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistanceM Mutlu, U Raza, Ö Saatci, E Eyüpoğlu, E Yurdusev, Ö ŞahinJournal of Molecular Medicine 94 (6), 629-644, 20161122016
2-) Heterozygous Deep‐Intronic Variants and Deletions in ABCA4 in Persons with Retinal Dystrophies and One Exonic ABCA4 VariantNM Bax, R Sangermano, S Roosing, AAHJ Thiadens, LH Hoefsloot, ...Human mutation 36 (1), 43-47, 2015732015
3-) miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancerM Mutlu, Ö Saatci, SA Ansari, E Yurdusev, H Shehwana, Ö Konu, U Raza, ...Scientific reports 6 (1), 1-14, 2016612016
4-) The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancerU Raza, Ö Saatci, S Uhlmann, SA Ansari, E Eyüpoğlu, E Yurdusev, ...Oncotarget 7 (31), 49859, 2016602016
5-) Functional radiogenetic profiling implicates ERCC6L2 in non-homologous end joiningP Francica, M Mutlu, VA Blomen, C Oliveira, Z Nowicka, A Trenner, ...Cell reports 32 (8), 2020422020